Ost-müük Exagen Inc. - XGN CFD
Lisa lemmikuks- Kokkuvõte
- Ajaloolised andmed
- Sündmused
- Tuluaruanne
- Bilanss
- Rahavood
- Omand
Kauplemistingimused
| Hinnavahe | 0.3744 | ||||||||
|
Pika positsiooni ööpäeva tasu
Long position overnight fee
Mine platvormile | -0.025457% | ||||||||
|
Lühikese positsiooni ööpäeva tasu
Short position overnight fee
Mine platvormile | 0.003235% | ||||||||
| Ööpäeva tasu aeg | 21:00 (UTC) | ||||||||
| Min kauplemise kogus | 1 | ||||||||
| Valuuta | USD | ||||||||
| Tagatis | 20% | ||||||||
| Aktsiabörs | United States of America | ||||||||
| Kauplemise vahendustasu | 0% |
*Information provided by Capital.com
Exagen Inc ESG Risk Ratings
High Medium Low Negligible
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Võtmestatistika
| Eelmine sulgemine* | 2.9147 |
| Avatud* | 2.9338 |
| Aastane muutus* | -38.62% |
| Päeva ulatus* | 2.9338 - 2.9551 |
| 52 nädala ulatus | 2.04-8.96 |
| Keskmine maht (10 päeva) | 18.61K |
| Keskmine maht (3 kuud) | 419.15K |
| Turukapitalisatsioon | 50.65M |
| P/E suhtarv | -100.00K |
| Ringluses olevad aktsiad | 16.83M |
| Tulu | 46.40M |
| EPS | -2.61 |
| Dividendid (% kasumist) | N/A |
| Beeta | 1.26 |
| Järgmine tuluaruande kuupäev | Aug 2, 2023 |
Kõigi andmete allikas on Refinitiv, välja arvatud tärniga märgitud, kus *-ga andmed on esitanud Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Sulgemishind | Change (%) | Avamishind | High | Low |
|---|---|---|---|---|---|---|
| Jun 1, 2023 | 2.9147 | 0.0784 | 2.76% | 2.8363 | 2.9147 | 2.8363 |
| May 31, 2023 | 2.9930 | 0.1175 | 4.09% | 2.8755 | 2.9930 | 2.8363 |
| May 30, 2023 | 2.8665 | -0.0288 | -0.99% | 2.8953 | 2.9351 | 2.8267 |
| May 26, 2023 | 2.8869 | 0.0063 | 0.22% | 2.8806 | 2.9453 | 2.7685 |
| May 25, 2023 | 2.8855 | -0.0931 | -3.13% | 2.9786 | 3.0574 | 2.8832 |
| May 24, 2023 | 2.9902 | 0.0488 | 1.66% | 2.9414 | 3.1076 | 2.8714 |
| May 23, 2023 | 3.0002 | 0.1545 | 5.43% | 2.8457 | 3.0302 | 2.8457 |
| May 22, 2023 | 2.9826 | 0.1088 | 3.79% | 2.8738 | 2.9832 | 2.7291 |
| May 19, 2023 | 2.9922 | -0.0384 | -1.27% | 3.0306 | 3.0406 | 2.9032 |
| May 18, 2023 | 3.0210 | 0.0990 | 3.39% | 2.9220 | 3.1168 | 2.9047 |
| May 17, 2023 | 3.0108 | -0.2424 | -7.45% | 3.2532 | 3.5374 | 2.9214 |
| May 16, 2023 | 3.3365 | 0.6429 | 23.87% | 2.6936 | 3.7417 | 2.6903 |
| May 15, 2023 | 2.6938 | 0.0100 | 0.37% | 2.6838 | 2.7036 | 2.6825 |
| May 12, 2023 | 2.6838 | -0.0573 | -2.09% | 2.7411 | 2.7609 | 2.6827 |
| May 11, 2023 | 2.7709 | 0.0300 | 1.09% | 2.7409 | 2.8199 | 2.7385 |
| May 10, 2023 | 2.7413 | -0.0500 | -1.79% | 2.7913 | 2.8295 | 2.7327 |
| May 9, 2023 | 2.7240 | 0.0874 | 3.31% | 2.6366 | 2.7327 | 2.6366 |
| May 8, 2023 | 2.6564 | 0.0776 | 3.01% | 2.5788 | 2.6954 | 2.5786 |
| May 5, 2023 | 2.5984 | 0.2037 | 8.51% | 2.3947 | 2.5986 | 2.3947 |
| May 4, 2023 | 2.4645 | 0.0978 | 4.13% | 2.3667 | 2.4927 | 2.3667 |
Exagen Inc. Events
| Kellaaeg (UTC) (UTC) | Riik | Sündmus |
|---|---|---|
| Wednesday, June 7, 2023 | ||
| Kellaaeg (UTC) (UTC) 19:00 | Riik US
| Sündmus Exagen Inc at William Blair Growth Stock Conference Exagen Inc at William Blair Growth Stock ConferenceForecast -Previous - |
| Friday, June 9, 2023 | ||
| Kellaaeg (UTC) (UTC) 15:00 | Riik US
| Sündmus Exagen Inc Annual Shareholders Meeting Exagen Inc Annual Shareholders MeetingForecast -Previous - |
| Wednesday, August 2, 2023 | ||
| Kellaaeg (UTC) (UTC) 20:00 | Riik US
| Sündmus Q2 2023 Exagen Inc Earnings Release Q2 2023 Exagen Inc Earnings ReleaseForecast -Previous - |
| Monday, November 13, 2023 | ||
| Kellaaeg (UTC) (UTC) 10:59 | Riik US
| Sündmus Q3 2023 Exagen Inc Earnings Release Q3 2023 Exagen Inc Earnings ReleaseForecast -Previous - |
- Aastas
- Kvartalis
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Kogutulu | 45.563 | 48.299 | 41.975 | 40.387 | 32.44 |
| Tulu | 45.563 | 48.299 | 41.975 | 40.387 | 32.44 |
| Kulud, Kokku | 24.214 | 20.588 | 16.559 | 18.808 | 15.379 |
| Brutokasum | 21.349 | 27.711 | 25.416 | 21.579 | 17.061 |
| Kogu tegevuskulu | 91.614 | 72.366 | 57.16 | 49.686 | 37.32 |
| Müük/Üldine/admin kulud, kokku | 52.018 | 44.541 | 37.033 | 28.702 | 19.675 |
| Uuringud ja arendus | 9.876 | 7.237 | 3.568 | 2.176 | 2.125 |
| Depreciation / Amortization | 0 | 0.141 | |||
| Intressikulu (tulu) - neto majandustegevusest | 0 | 0 | |||
| Ootamatud kulutused (tulu) | 5.506 | 0 | 0 | ||
| Tulud majandustegevusest | -46.051 | -24.067 | -15.185 | -9.299 | -4.88 |
| Intressitulud (kulu), muud tulud, neto | -2.448 | -2.625 | -2.565 | -3.224 | -3.186 |
| Muud, neto | 0.83 | 0.016 | 0.984 | 0.51 | 0.112 |
| Netotulu enne makse | -47.669 | -26.676 | -16.766 | -12.013 | -7.954 |
| Netotulu pärast makse | -47.387 | -26.851 | -16.687 | -12.038 | -8.012 |
| Netotulu enne erikulusid | -47.387 | -26.851 | -16.687 | -12.038 | -8.012 |
| Netotulu | -47.387 | -26.851 | -16.687 | -12.038 | -8.012 |
| Total Adjustments to Net Income | 0 | -18.241 | -10.47 | ||
| Arvestatav tulu, v a erikulud | -47.387 | -26.851 | -16.687 | -30.279 | -18.482 |
| Arvestatav tulu, koos erikuludega | -47.387 | -26.851 | -16.687 | -30.279 | -18.482 |
| Jaotuse korrigeerimine | |||||
| Jaotamisele kuuluv netotulu | -47.387 | -26.851 | -16.687 | -30.279 | -18.482 |
| Keskmine jaotamisele kuuluv aktsia kohta | 17.0823 | 15.9723 | 12.6328 | 12.561 | 11.5779 |
| Jaotatav EPS, v a erakorralised kulud | -2.77403 | -1.6811 | -1.32093 | -2.41056 | -1.59631 |
| Dividends per Share - Common Stock Primary Issue | |||||
| Jaotamisele kuuluv normaal-EPS | -2.56452 | -1.6811 | -1.32093 | -2.41056 | -1.59631 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Kogutulu | 11.23 | 12.837 | 14.726 | 7.606 | 10.394 |
| Tulu | 11.23 | 12.837 | 14.726 | 7.606 | 10.394 |
| Kulud, Kokku | 5.926 | 6.309 | 6.01 | 6.078 | 5.817 |
| Brutokasum | 5.304 | 6.528 | 8.716 | 1.528 | 4.577 |
| Kogu tegevuskulu | 18.936 | 27.328 | 22.543 | 21.67 | 20.073 |
| Müük/Üldine/admin kulud, kokku | 11.884 | 12.812 | 14.151 | 12.903 | 12.152 |
| Uuringud ja arendus | 1.126 | 2.701 | 2.382 | 2.689 | 2.104 |
| Tulud majandustegevusest | -7.706 | -14.491 | -7.817 | -14.064 | -9.679 |
| Intressitulud (kulu), muud tulud, neto | -0.638 | -0.626 | -0.618 | -0.606 | -0.598 |
| Muud, neto | 0.656 | 0.481 | 0.339 | 0.005 | 0.005 |
| Netotulu enne makse | -7.688 | -14.636 | -8.096 | -14.665 | -10.272 |
| Netotulu pärast makse | -7.688 | -14.354 | -8.096 | -14.665 | -10.272 |
| Netotulu enne erikulusid | -7.688 | -14.354 | -8.096 | -14.665 | -10.272 |
| Netotulu | -7.688 | -14.354 | -8.096 | -14.665 | -10.272 |
| Arvestatav tulu, v a erikulud | -7.688 | -14.354 | -8.096 | -14.665 | -10.272 |
| Arvestatav tulu, koos erikuludega | -7.688 | -14.354 | -8.096 | -14.665 | -10.272 |
| Jaotamisele kuuluv netotulu | -7.688 | -14.354 | -8.096 | -14.665 | -10.272 |
| Keskmine jaotamisele kuuluv aktsia kohta | 17.5268 | 17.1955 | 17.081 | 17.0585 | 16.9924 |
| Jaotatav EPS, v a erakorralised kulud | -0.43864 | -0.83475 | -0.47398 | -0.85969 | -0.60451 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Jaotamisele kuuluv normaal-EPS | -0.43864 | -0.62662 | -0.47398 | -0.85969 | -0.60451 |
| Ootamatud kulutused (tulu) | 5.506 |
- Aastas
- Kvartalis
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Käibevarad kokku | 72.611 | 112.734 | 70.517 | 81.25 | 21.312 |
| Raha ja lühiajalised investeeringud | 62.391 | 99.442 | 57.448 | 72.084 | 13.164 |
| Raha ja ekvivalendid | 62.391 | 99.442 | 57.448 | 72.084 | 13.164 |
| Laekumata arved, neto | 6.077 | 9.654 | 8.91 | 5.715 | 5.952 |
| Accounts Receivable - Trade, Net | 6.077 | 9.654 | 8.91 | 5.715 | 5.952 |
| Prepaid Expenses | 4.143 | 3.638 | 4.159 | 3.451 | 2.196 |
| Total Assets | 86.221 | 123.445 | 78.375 | 88.31 | 28.887 |
| Property/Plant/Equipment, Total - Net | 13.082 | 4.772 | 2.102 | 1.38 | 1.566 |
| Property/Plant/Equipment, Total - Gross | 18.206 | 8.656 | |||
| Accumulated Depreciation, Total | -5.124 | -3.884 | |||
| Goodwill, Net | 0 | 5.506 | 5.506 | 5.506 | 5.506 |
| Intangibles, Net | 0 | ||||
| Other Long Term Assets, Total | 0.528 | 0.433 | 0.25 | 0.174 | 0.503 |
| Total Current Liabilities | 9.623 | 9.318 | 8.771 | 5.895 | 8.952 |
| Accounts Payable | 3.046 | 2.492 | 3.014 | 1.476 | 1.279 |
| Accrued Expenses | 5.242 | 6.239 | 5.449 | 4.419 | 3.923 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 0.89 | 0.587 | 0.308 | ||
| Other Current Liabilities, Total | 0.445 | 0 | 3.75 | ||
| Total Liabilities | 43.761 | 38.509 | 36.536 | 32.651 | 35.621 |
| Total Long Term Debt | 29.626 | 27.478 | 26.659 | 25.854 | 24.617 |
| Other Liabilities, Total | 4.512 | 1.407 | 0.948 | 0.638 | 1.807 |
| Total Equity | 42.46 | 84.936 | 41.839 | 55.659 | -6.734 |
| Redeemable Preferred Stock | 0 | 105.232 | |||
| Common Stock | 0.017 | 0.016 | 0.013 | 0.013 | 0.012 |
| Additional Paid-In Capital | 297.97 | 293.06 | 223.115 | 220.248 | 40.586 |
| Retained Earnings (Accumulated Deficit) | -255.527 | -208.14 | -181.289 | -164.602 | -152.564 |
| Total Liabilities & Shareholders’ Equity | 86.221 | 123.445 | 78.375 | 88.31 | 28.887 |
| Total Common Shares Outstanding | 16.55 | 16.165 | 12.6523 | 12.561 | 11.5779 |
| Long Term Debt | 28.778 | 27.478 | 26.659 | 25.854 | 24.617 |
| Deferred Income Tax | 0 | 0.306 | 0.158 | 0.264 | 0.245 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | ||
| Capital Lease Obligations | 0.848 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Käibevarad kokku | 65.716 | 72.611 | 82.06 | 88.164 | 103.636 |
| Raha ja lühiajalised investeeringud | 52.184 | 62.391 | 68.704 | 76.387 | 89.751 |
| Raha ja ekvivalendid | 52.184 | 62.391 | 68.704 | 76.387 | 89.751 |
| Laekumata arved, neto | 9.303 | 6.077 | 10.639 | 8.715 | 10.911 |
| Accounts Receivable - Trade, Net | 9.303 | 6.077 | 10.639 | 8.715 | 10.911 |
| Prepaid Expenses | 4.229 | 4.143 | 2.717 | 3.062 | 2.974 |
| Total Assets | 79.234 | 86.221 | 101.597 | 106.849 | 122.044 |
| Property/Plant/Equipment, Total - Net | 12.915 | 13.082 | 13.445 | 12.554 | 12.201 |
| Property/Plant/Equipment, Total - Gross | 18.585 | 18.206 | 18.352 | 17.026 | 16.363 |
| Accumulated Depreciation, Total | -5.67 | -5.124 | -4.907 | -4.472 | -4.162 |
| Goodwill, Net | 0 | 5.506 | 5.506 | 5.506 | |
| Other Long Term Assets, Total | 0.603 | 0.528 | 0.586 | 0.625 | 0.701 |
| Total Current Liabilities | 9.268 | 9.623 | 11.332 | 10.054 | 11.884 |
| Accounts Payable | 1.878 | 3.046 | 3.669 | 3.105 | 4.214 |
| Accrued Expenses | 6.041 | 5.242 | 6.488 | 5.789 | 7.078 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Current Port. of LT Debt/Capital Leases | 0.904 | 0.89 | 0.73 | 0.679 | 0.592 |
| Total Liabilities | 43.297 | 43.761 | 45.411 | 44.025 | 45.888 |
| Total Long Term Debt | 29.092 | 29.626 | 28.982 | 28.609 | 28.395 |
| Long Term Debt | 29.092 | 28.778 | 28.008 | 27.828 | 27.651 |
| Deferred Income Tax | 0 | 0.306 | 0.306 | 0.306 | |
| Other Liabilities, Total | 4.937 | 4.512 | 4.791 | 5.056 | 5.303 |
| Total Equity | 35.937 | 42.46 | 56.186 | 62.824 | 76.156 |
| Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | |
| Common Stock | 0.017 | 0.017 | 0.016 | 0.016 | 0.016 |
| Additional Paid-In Capital | 299.135 | 297.97 | 297.343 | 295.885 | 294.552 |
| Retained Earnings (Accumulated Deficit) | -263.215 | -255.527 | -241.173 | -233.077 | -218.412 |
| Total Liabilities & Shareholders’ Equity | 79.234 | 86.221 | 101.597 | 106.849 | 122.044 |
| Total Common Shares Outstanding | 16.827 | 16.55 | 16.3055 | 16.2588 | 16.2312 |
| Capital Lease Obligations | 0.848 | 0.974 | 0.781 | 0.744 | |
| Other Current Liabilities, Total | 0.445 | 0.445 | 0.445 | 0.481 |
- Aastas
- Kvartalis
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Netotulu/algväärtus | -47.387 | -26.851 | -16.687 | -12.038 | -8.012 |
| Raha majandustegevusest | -32.144 | -20.269 | -14.084 | -9.711 | -9.301 |
| Raha majandustegevusest | 1.557 | 0.948 | 0.546 | 0.591 | 0.731 |
| Deferred Taxes | -0.306 | 0.148 | -0.106 | 0 | 0.031 |
| Mittelikviidsed varad | 12.322 | 5.547 | 3.499 | 1.562 | 1.54 |
| Makstud intressid | 1.732 | 1.815 | 1.758 | 2.288 | 1.73 |
| Muutused tööjõus | 1.67 | -0.061 | -1.336 | 0.174 | -3.591 |
| Tulu investeeringutelt | -4.318 | -2.42 | -0.455 | -0.103 | -0.199 |
| Kapitalikulutused | -4.318 | -2.42 | -0.455 | -0.403 | -0.199 |
| Muud rahavood investeeringutelt, kokku | 0 | 0.3 | 0 | ||
| Rahavood investeeringutelt | -0.489 | 64.683 | -0.097 | 68.734 | 11.423 |
| Rahavoogudesse investeerimine | -0.239 | -4.447 | -0.021 | 0 | |
| Aktsiate emiteerimine (tagasiost), neto | 0.446 | 69.655 | 0.173 | 68.872 | 6.466 |
| Laenu väljastamine (kustutamine), neto | -0.696 | -0.525 | -0.249 | -0.138 | 4.957 |
| Rahaline kogumuutus | -36.951 | 41.994 | -14.636 | 58.92 | 1.923 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -7.688 | -47.387 | -33.033 | -24.937 | -10.272 |
| Cash From Operating Activities | -9.749 | -32.144 | -26.41 | -19.728 | -8.574 |
| Cash From Operating Activities | 0.553 | 1.557 | 1.037 | 0.597 | 0.283 |
| Deferred Taxes | -0.306 | ||||
| Non-Cash Items | 1.454 | 12.322 | 5.423 | 3.68 | 1.768 |
| Cash Interest Paid | 0.449 | 1.732 | 1.297 | 0.86 | 0.424 |
| Changes in Working Capital | -4.068 | 1.67 | 0.163 | 0.932 | -0.353 |
| Cash From Investing Activities | -0.396 | -4.318 | -3.912 | -3.033 | -1.087 |
| Capital Expenditures | -0.396 | -4.318 | -3.912 | -3.033 | -1.087 |
| Cash From Financing Activities | -0.062 | -0.489 | -0.316 | -0.294 | -0.03 |
| Financing Cash Flow Items | 0 | -0.239 | -0.224 | -0.222 | -0.115 |
| Issuance (Retirement) of Stock, Net | 0.179 | 0.446 | 0.385 | 0.231 | 0.231 |
| Issuance (Retirement) of Debt, Net | -0.241 | -0.696 | -0.477 | -0.303 | -0.146 |
| Net Change in Cash | -10.207 | -36.951 | -30.638 | -23.055 | -9.691 |
| Investori nimi | Investori liik | Ringluse protsent | Hoitud osakud | Muutus osakutes | Hoidmise kuupäev | Hinnang käibele |
|---|---|---|---|---|---|---|
| NMSIC Co-Investment Fund, L.P | Corporation | 13.7228 | 2308958 | 0 | 2022-12-31 | |
| H.I.G. Capital, LLC | Private Equity | 10.0813 | 1696252 | 0 | 2023-04-18 | LOW |
| Tullis Health Investors | Venture Capital | 9.0081 | 1515672 | 0 | 2022-12-31 | |
| RTW Investments L.P. | Investment Advisor/Hedge Fund | 8.2682 | 1391184 | 26848 | 2023-03-31 | LOW |
| Stonepine Capital Management, LLC | Investment Advisor/Hedge Fund | 6.1636 | 1037074 | 183032 | 2023-03-31 | MED |
| Hunt Holdings, L.P | Corporation | 6.0106 | 1011324 | -196683 | 2021-12-31 | |
| Wasatch Global Investors Inc | Investment Advisor/Hedge Fund | 5.9466 | 1000561 | 0 | 2023-03-31 | LOW |
| Cowen & Co., LLC | Research Firm | 5.6078 | 943552 | -22470 | 2023-03-31 | MED |
| Lytton (Laurence W) | Individual Investor | 5.1777 | 871181 | 37876 | 2022-12-31 | MED |
| Silvercrest Asset Management Group LLC | Investment Advisor/Hedge Fund | 2.9872 | 502615 | 0 | 2023-03-31 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.9178 | 490944 | 0 | 2023-03-31 | LOW |
| Morgan Stanley & Co. LLC | Research Firm | 2.8592 | 481072 | -3829 | 2023-03-31 | MED |
| Rocca (Fortunato Ron) | Individual Investor | 1.6496 | 277562 | 269384 | 2023-04-18 | HIGH |
| Perkins Capital Management, Inc. | Investment Advisor | 1.5447 | 259905 | 7500 | 2023-03-31 | LOW |
| Florida State Board of Administration | Pension Fund | 0.9102 | 153143 | 43988 | 2022-09-30 | LOW |
| Nantahala Capital Management, LLC | Hedge Fund | 0.7882 | 132613 | -13946 | 2023-03-31 | LOW |
| UBS Financial Services, Inc. | Investment Advisor | 0.7776 | 130833 | -6015 | 2023-03-31 | LOW |
| Zack (Debra Jeske) | Individual Investor | 0.6509 | 109519 | 103385 | 2023-04-18 | |
| Aballi (John) | Individual Investor | 0.5349 | 90000 | 0 | 2023-04-18 | LOW |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.4457 | 75000 | 0 | 2023-03-31 | LOW |
Miks valida Capital.com? Meie numbrid räägivad iseenda eest.
Capital.com Group535K+
Kauplejad
87K+
Igakuiste aktiivsete klientide arv
$113M+
Igakuine investeerimise maht
$64M+
Igakuiselt välja võetud
Kauplemiskalkulaator
Arvutage oma hüpoteetiline võit/kaotus, kui oleksite avanud CFD-tehingu ühel kindlal kuupäeval (valige kuupäev) ja sulgenud teisel kuupäeval (valige kuupäev).
Kauplemise vahendustasu
0
- 1:1
Finantsvõimendus
1:1
- 20
- 100
- 500
- 1000
- 10000
Investeering
Tehingu suurus (võimendus x investeering):
Avamishind
Close
Lühike Pikk
Exagen Inc. Company profile
Ettevõttest Exagen Inc.
Exagen Inc. on ärilises etapis olev bioteaduste ettevõte. Ettevõte pakub arstidele teste patsientidele ja tervishoiuteenuse osutajatele autoimmuunhaiguste diagnoosimiseks, prognoosimiseks ja jälgimiseks. Ettevõte arendab ja turustab testimistooteid kaubamärgi AVISE all. Ettevõtte juhtiv testimisvahend AVISE võimaldab diagnoosida patsiente, kellel on sidekoehaiguste ( CTD) ja süsteemse erütematoosse luupuse (SLE) sümptomid. Ettevõtte teiste diagnostiliste testide hulka kuuluvad AVISE Lupus ja AVISE antiphospholipid sündroom (APS). Prognoositestide hulka kuuluvad AVISE Systemic lupus erythematosus (SLE) Prognostic, AVISE Anti- carbamylated proteins (CarP) ja AVISE Platelet-bound C4d (PC4d). Seiretestide hulka kuuluvad AVISE SLE Monitor, AVISE metotreksaat (MTX) ja AVISE hüdroksüklorokiin (HCQ).
| Industry: | Healthcare Facilities & Services (NEC) |
1261 Liberty Way Ste C
92081-8356
Tuluaruanne
- Annual
- Quarterly
Teised on vaadanud veel
Kas otsite jätkuvalt vahendajat, keda saab usaldada?
Ühinege 535,000+ kauplejaga üle kogu maailma, kes valisid kauplemiseks veebisaidi Capital.com